adenine and gdc-0973

adenine has been researched along with gdc-0973 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bagby, SM; Burstyn-Cohen, T; Carrico, J; DeRyckere, D; Earp, HS; Eckhardt, SG; Frye, SV; Graham, DK; Kami, R; Minson, KA; Robinson, WA; Sinik, L; Tentler, JJ; Wang, X	1

Other Studies

1 other study(ies) available for adenine and gdc-0973

Article	Year
Inhibition of MERTK Promotes Suppression of Tumor Growth in BRAF Mutant and BRAF Wild-Type Melanoma. Molecular cancer therapeutics, 2019, Volume: 18, Issue:2 Topics: Adenine; Animals; Azetidines; c-Mer Tyrosine Kinase; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Female; GTP Phosphohydrolases; Humans; Melanoma; Membrane Proteins; Mice; Mutation; Phosphorylation; Piperazines; Piperidines; Proto-Oncogene Proteins B-raf; Signal Transduction; Vemurafenib	2019

Article

Year

Inhibition of MERTK Promotes Suppression of Tumor Growth in BRAF Mutant and BRAF Wild-Type Melanoma.

Molecular cancer therapeutics, 2019, Volume: 18, Issue:2

Topics: Adenine; Animals; Azetidines; c-Mer Tyrosine Kinase; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Female; GTP Phosphohydrolases; Humans; Melanoma; Membrane Proteins; Mice; Mutation; Phosphorylation; Piperazines; Piperidines; Proto-Oncogene Proteins B-raf; Signal Transduction; Vemurafenib

2019